MycoMedica Life Sciences, PBC Stock

Psychedelic Medicines

Sign up today and learn more about MycoMedica Life Sciences, PBC Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About MycoMedica Life Sciences, PBC Stock

Founded by world-renowned mycologist Paul Stamets, MycoMedica, PBC is a lifesciences company developing therapeutic drugs derived from fungi to help people live healthier, better lives. Our breakthrough innovation, the Stamets Stack, uses a novel combination of ingredients – not found together in nature – to unlock the potential effectiveness of psilocybin in the prevention and treatment of psychiatric and neurological disorders. More information is available at www.mycomedica.bio.

Funding History

May 2021$8.0M
June 2022$60.0M

Management

Co-founder & Managing Director, Obvious Ventures

James Joaquin

Co-Founder and Chief Executive Officer

Paul Stamets

Co-Founder and Chief Financial Officer

Tad Buchanan

President and Chief Medical Officer

Sanjay Dubé M.D.

President and Chief Medical Officer

Sanjay Dubé M.D.

Co-Founder & Scientific and Medical Advisor

Pamela Kryskow M.D.

Vice President and Head of Operations (Development)

Joanna Bolger

Co-Founder & Chief Financial Officer

Tad Buchanan

Chief Scientific Officer

Nick Moore

Co-founder and CEO, MycoMedica Life Sciences, PBC

Paul Stamets

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo